Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
2019 Pharmaceutical Industry and Regulators Symposium Recording - Day 1, Part 1
Aiding and standardising expert review under ICH M7pdf file
Aiding and standardising expert review under ICH M7 - Recording
Application of AOPs for Weight-of-Evidence Assessments: Rationalising Evidence for the ICH S1B(R1) Guidance Addendumpdf fileKaptis
Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledgeKaptis
Comparing and combining in silico outcomes and in vitro mechanism-based assays to predict genotoxicitypdf fileDerek NexusVitic
Data Dos and Don’ts In Building Statistical Models For Ames Mutagenicitypdf fileSarah Nexus
Development of a network of carcinogenicity adverse outcome pathways and its employment as an evidence framework for safety assessmentKaptis
Drawing Conventions.pdfpdf fileDerek Nexus
Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendumKaptis
Evaluation Of A Statistics-based Ames Mutagenicity QSAR Model And Interpretation Of The Results ObtainedSarah Nexus
Evaluation Of The Statistics-Based Ames Mutagenicity Model Sarah Nexus And Interpretation Of The Results ObtainedSarah Nexus
Future Developments AOP Networks And Predicting Secondary Pharmacologypdf fileEffirisKaptis
How Sarah Nexus PredictsSarah Nexus
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectDerek NexusSarah Nexus
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental Data_EMGS Data Challenge 2020pdf fileKaptisDerek NexusVitic
Linking Evidence With AOPs To Produce Integrated Approaches to Testing and Assessment (IATA)pdf fileKaptis
Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updatesDerek NexusSarah NexusVitic
Modelling Simple Toxicity Endpoints: Alerts, (Q)SARs and BeyondDerek NexusMeteor NexusSarah NexusVitic
Nexus ICH M7 Expert Review Support Functionality (an infographic)pdf fileDerek NexusSarah Nexus
Resolving conflicting data sources to a single call in Sarah Nexus [an infographic]pdf fileSarah Nexus
Session 4 - Combining knowledge and data on an AOP framework in order to take advantage of new and emerging methods In genotoxicity assessment - Recording
Session 4 - Combining knowledge and data on an AOP framework in order to take advantage of new and emerging methods In genotoxicity assessment - Slidespdf file
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7Derek NexusSarah Nexus
Using Data Associated with a Developmental and Reproductive Toxicity Adverse Outcome Network to Aid Safety Assessmentspdf file

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).